Physician profile
Michael A Nicolas
NPI 1497284202
$4,892.02
in general payments reported to CMS, 2019-2025
18 companies · $25.65 in 2025
The $25.65 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $297 · 2022: $2,545 · 2023: $2,025 · 2025: $25.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $765.24 | 2022-2023 | Austedo, Austedo Xr, Uzedy |
| Abbvie INC. | $615.63 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $504.81 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $473.30 | 2022-2023 | Invega Trinza, Invega Sustenna, Invega |
| Alkermes, INC. | $379.97 | 2022-2023 | Lybalvi, Aristada |
| Otsuka America Pharmaceutical, INC. | $335.05 | 2021-2023 | Abilify Maintena, Rexulti, Abilify Mycite |
| Vanda Pharmaceuticals INC. | $322.51 | 2022-2023 | Hetlioz, Fanapt |
| Neurocrine Biosciences, INC. | $299.96 | 2022-2023 | Ingrezza |
| Indivior INC. | $257.07 | 2021-2022 | |
| Novo Nordisk INC | $221.94 | 2022-2023 | Wegovy, Saxenda |
| Sunovion Pharmaceuticals INC. | $201.79 | 2022 | |
| Lundbeck LLC | $181.22 | 2021-2023 | Rexulti |
| Biogen, INC. | $95.81 | 2021 | |
| Axsome Therapeutics, INC. | $60.54 | 2022-2023 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $60.45 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $59.40 | 2022-2023 | Jornay Pm |
| Noven Therapeutics, LLC | $39.37 | 2021-2022 | |
| Eisai INC. | $17.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Nicolas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.